{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:40:47Z","timestamp":1780324847221,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.peptides.2020.170420","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T21:17:14Z","timestamp":1602537434000},"page":"170420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The contribution of cardiac and extracardiac factors to NT-proBNP concentrations in patients with advanced heart failure before and after left ventricular assist device implantation"],"prefix":"10.1016","volume":"135","author":[{"given":"Marie Sophie S.","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Eismark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Wolsk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2020.170420_bib0005","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2020.170420_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11010-008-9779-4","article-title":"B-type natriuretic peptide and wall stress in dilated human heart","volume":"314","author":"Alter","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.peptides.2020.170420_bib0015","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2005.11.030","article-title":"B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure","volume":"47","author":"Iwanaga","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2020.170420_bib0020","first-page":"H1684","article-title":"Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure","volume":"274","author":"Luchner","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.peptides.2020.170420_bib0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0008-6363(01)00195-X","article-title":"Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use","volume":"51","author":"Boomsma","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.peptides.2020.170420_bib0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","article-title":"Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure","volume":"90","author":"Yasue","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2020.170420_bib0035","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/eurjhf\/hft048","article-title":"Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors","volume":"15","author":"Luchner","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.peptides.2020.170420_bib0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.athoracsur.2016.12.018","article-title":"Changes in end-organ function in patients with prolonged continuous-flow left ventricular assist device support","volume":"103","author":"Yoshioka","year":"2017","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.peptides.2020.170420_bib0045","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.hlc.2016.10.011","article-title":"The effect of left ventricular assist device implantation on serum albumin, total protein and body mass: a short-term, longitudinal follow-up study","volume":"26","author":"Guvenc","year":"2017","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.peptides.2020.170420_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.healun.2012.09.024","article-title":"Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist device","volume":"32","author":"Emani","year":"2013","journal-title":"J. Heart Lung Transplant"},{"key":"10.1016\/j.peptides.2020.170420_bib0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/17434440.2018.1437346","article-title":"Effects of continuous and pulsatile flows generated by ventricular assist devices on renal function and pathology","volume":"15","author":"Miyamoto","year":"2018","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.peptides.2020.170420_bib0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jchf.2014.06.013","article-title":"Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury","volume":"3","author":"Ahmad","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.peptides.2020.170420_bib0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.amjcard.2014.07.056","article-title":"Early trends in N-Terminal pro\u2013Brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure","volume":"114","author":"Hasin","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.peptides.2020.170420_bib0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.healun.2005.09.007","article-title":"Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device","volume":"25","author":"Bruggink","year":"2006","journal-title":"J. Heart Lung Transplant"},{"key":"10.1016\/j.peptides.2020.170420_bib0075","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1373\/clinchem.2003.030510","article-title":"B-type natriuretic peptide (BNP) and N-terminal proBNP in patients with end-stage heart failure supported by a left ventricular assist device","volume":"50","author":"Kemperman","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.peptides.2020.170420_bib0080","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/S0735-1097(01)01677-1","article-title":"Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems","volume":"38","author":"Sodian","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"56","key":"10.1016\/j.peptides.2020.170420_bib0085","first-page":"527","article-title":"B-type natriuretic peptide levels and continuous-flow left ventricular assist devices","volume":"2010","author":"Sareyyupoglu","year":"1992","journal-title":"ASAIO J."},{"key":"10.1016\/j.peptides.2020.170420_bib0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.peptides.2012.05.018","article-title":"The natriuretic peptide time-course in end-stage heart failure patients supported by left ventricular assist device implant: focus on NT-proCNP","volume":"36","author":"Cabiati","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2020.170420_bib0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","article-title":"Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension","volume":"31","author":"Nagaya","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2020.170420_bib0100","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar3876","article-title":"N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study","volume":"14","author":"Thakkar","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"18","key":"10.1016\/j.peptides.2020.170420_bib0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.peptides.2020.170420_bib0110","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.116.024976","article-title":"Impact of body mass index on the accuracy of N-Terminal pro-brain natriuretic peptide and brain natriuretic peptide for predicting outcomes in patients with chronic heart failure and reduced ejection fraction","volume":"134","author":"Nadruz","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2020.170420_bib0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.hrtlng.2017.01.005","article-title":"Relationship among body mass index, NT-proBNP, and mortality in decompensated chronic heart failure","volume":"46","author":"Scrutinio","year":"2017","journal-title":"Heart Lung J. Crit. Care"},{"key":"10.1016\/j.peptides.2020.170420_bib0120","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","article-title":"ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure","volume":"49","author":"Fonarow","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2020.170420_bib0125","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.peptides.2020.170420_bib0130","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.peptides.2020.170420_bib0135","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Candesartan in heart failure: assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.peptides.2020.170420_bib0140","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2020.170420_bib0145","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jacc.2013.10.017","article-title":"Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center?","volume":"63","author":"Thorvaldsen","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"61","key":"10.1016\/j.peptides.2020.170420_bib0150","first-page":"156","article-title":"B-type natriuretic peptide-guided therapy and length of hospital stay post left ventricular assist device implantation","volume":"2015","author":"Hellman","year":"1992","journal-title":"ASAIO J."},{"key":"10.1016\/j.peptides.2020.170420_bib0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1053-2498(01)00289-3","article-title":"The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types","volume":"20","author":"Milting","year":"2001","journal-title":"J. Heart Lung Transplant"},{"key":"10.1016\/j.peptides.2020.170420_bib0160","first-page":"765","article-title":"Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy","volume":"16","author":"Altemose","year":"1997","journal-title":"J. Heart Lung Transplant"},{"key":"10.1016\/j.peptides.2020.170420_bib0165","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.hlc.2014.04.259","article-title":"Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy","volume":"23","author":"Gupta","year":"2014","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.peptides.2020.170420_bib0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5507\/bp.2017.003","article-title":"Clinical correlates of B-type natriuretic peptide monitoring in outpatients with left ventricular assist device","volume":"161","author":"Hegarova","year":"2017","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky. Olomouc Czechoslov"},{"issue":"61","key":"10.1016\/j.peptides.2020.170420_bib0175","first-page":"373","article-title":"Serum brain natriuretic peptide concentration 60 days after surgery as a predictor of long-term prognosis in patients implanted with a left ventricular assist device","volume":"2015","author":"Sato","year":"1992","journal-title":"ASAIO J."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120301698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120301698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:28:38Z","timestamp":1759310918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978120301698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"alternative-id":["S0196978120301698"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170420","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of cardiac and extracardiac factors to NT-proBNP concentrations in patients with advanced heart failure before and after left ventricular assist device implantation","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170420"}}